Welcome to ADAPT SMART … enabling platform for the coordination of Medicines Adaptive Pathways to Patients (MAPPs) activities. MAPPs seeks to foster access to beneficial treatments for the right patient groups at the earliest appropriate time in the product life-span in a sustainable fashion.
- Distribute findings, key discoveries and case studies from ongoing or completed MAPPs pilot projects, creating a MAPPs repository of knowledge and opportunities
- Identify the scientific challenges and opportunities related to the implementation of MAPPs and foster the aligned understanding of consortium members and their constituents
- Support new IMI2 research and innovation actions by facilitating the inclusion of MAPPs enablers, tools and methodologies to address its challenges and opportunities
- Conduct horizon scanning and research on key topics to produce actionable advice and recommendations for IMI and other stakeholders to further the broad implementation and adoption of MAPPs
Webinar: “Adaptive Pathways and Eastern European countries”
21 March 2018, 13.00 - 14.00 CET Adaptive Pathways (or Medicine Adaptive Pathways to Patients (MAPPs)) are a potential tool to place new, innovative medicines into the market for those patients at greatest unmet need. This webinar will discuss how Eastern European countries deal with truly innovative drugs entering the market.
ADAPT SMART Closing Event, 21-22 March 2018, Budapest
We are pleased to announce that the IMI ADAPT SMART Closing Meeting "Medicines Development in the Adaptive Era" will take place on the 21st and 22nd March 2018 in the Akadémia Klub (the Hungarian Academy of Sciences), Budapest, Hungary.
During this event the final results of the project will be presented and placed into the context of public health and sustainable pharmaceutical innovation in Europe and beyond.
DIA Value, Access and Regulatory Strategy Workshop
25 Oct 2017 8:00 AM – 26 Oct 2017 3:30 PM CET Radisson Blu Steinentorstrasse 25 4001 Basel Switzerland